Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2025

Share-Based Payment Arrangement [Abstract]

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award

Shares Available for Grant at December 31, 2025 349,081 

The following table summarizes information about stock option activity for the year ended December 31, 2025.

	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)	Aggregate Intrinsic Value
Outstanding at January 1, 2025	246,453	$	29.50
Granted	—	$	—
Exercised	(10,813)	$	23.74
Forfeited	(6,485)	$	27.37
Outstanding at December 31, 2025	229,155	$	29.83	3.69	$	486
Vested at Period-End	204,615	$	29.55	3.32	$	484
Expected to Vest	24,540	$	32.15	6.78	$	2

The following table summarizes the activity for the year ended December 31, 2023.

	Restricted Stock Units	Weighted Average Grant Date Fair Value
Non-vested at January 1, 2023	13,925	$	30.47
Granted	5,164	31.47
Vested	(19,089)	30.74
Non-vested at December 31, 2023	—	—

Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity

The following table summarizes information about restricted stock awards for the year ended December 31, 2025:

	Restricted Stock Awards	Weighted Average Grant Date Fair Value
Outstanding at January 1, 2025	21,818	24.54
Granted	43,250	27.50
Vested	(11,504)	25.68
Forfeited	—	—
Outstanding at December 31, 2025	53,564	26.68

Share-Based Payment Arrangement, Expensed and Capitalized, Amount

The following table presents information on the amounts expensed related to restricted stock awards.

	For the Year Ended December 31,
	2025		2024
Amount expensed	$	546	$	90

Other Stock Based Compensation Disclosure Table

The following is the Schedule of Other Information on restricted stock awards.

	2025
Restricted Stock Awards Granted	43,250
Weighted Average Grant Date Information:
Fair Value of Awards Granted	$	27.50
Total Grant Date Fair Value of Awards Granted in Period	$	1,189
Total Fair Value of Awards Vested in Period	$	300
Amount Expensed During the Year	$	546
Compensation Costs for Non-vested Awards Not Yet Recognized	$	1,099
Weighted Average Expected Vesting Period, In Years	2.78

The following is the Schedule of Other Information on Stock Options Granted.

	2025			2024			2023
Stock Options Granted	—			—			57,680
Weighted Average Grant Date Information:
Fair Value of Options Granted	$	—		$	—		$	7.78
Fair Value Assumptions:
Dividend Yield	—		%	—		%	3.30		%
Expected Volatility	—		%	—		%	28.38		%
Risk Free Interest Rate	—		%	—		%	3.57		%
Expected Lives (in years)	0			0			8.34
Amount Expensed During the Year	$	104		$	197		$	284
Compensation Costs for Non-vested Awards Not Yet Recognized	68			201			536
Weighted Average Expected Vesting Period, In Years	1.04			1.77			2.29
Proceeds From Stock Options Exercised	$	256		$	433		$	96
Tax Benefits Related to Stock Options Exercised	120			34			11
Intrinsic Value of Stock Options Exercised	65			115			34

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range

The following is the Schedule of Stock Options Granted Under the Long Term Incentive Plan by Exercise Price Range.

	Exercise Price Ranges
	$19.99 to $20.41		$27.04 to $27.47		$30.26		$31.34 to $33.78		Total
Outstanding at December 31, 2025
Number of Stock Options Outstanding	7,608		81,059		27,687		112,801		229,155
Weighted-Average Remaining Contractual Life (in years)	0.07		2.81		0.91		5.25		3.69
Weighted-Average Exercise Price	$	20.41	$	27.27	$	30.26	$	32.20	$	29.83
Vested at December 31, 2025
Number of Stock Options Outstanding	7,608		81,059		27,687		88,261		204,615
Weighted-Average Remaining Contractual Life (in years)	0.07		2.81		0.91		4.82		3.32
Weighted-Average Exercise Price	$	20.41	$	27.27	$	30.26	$	32.21	$	29.55

Schedule of Employee Stock Ownership Plan (ESOP) Disclosures

Schedule of ESOP Compensation Expense

	2025		2024		2023
ESOP Compensation Expense	$	1,893	$	1,879	$	1,540